Homepage – Revolutionizing how we prevent and treat diseases

Revolutionizing how we prevent and treat diseases

Home
About
- Video
- Funding
- Nanoscale
Research
Partners
- Researchers
- Institutions
Publications
Seminars
Videos
Links
Contacts

The Nanovaccine Institute is a consortium of 67 researchers at 20 universities, research institutes, national laboratories, and companies, coordinated by Iowa State University. Our research is an interdisciplinary merger of expertise in immunology, nanotechnology, materials science, microbiology, neuroscience, cancer biology, gerontology, clinical science, and social science. We are developing nanovaccines and nanotherapeutics for respiratory infections, neural disorders, tropical diseases, cancer, aging, and veterinary diseases. Our vision is that nanovaccines and nanotherapeutics will revolutionize how we prevent and treat disease.

Researchers hunt for next pandemic human flu virus in county fair pigs

A handful of Midwestern scientists are quietly hunting in an unlikely place for the next pandemic flu virus capable of killing thousands of people -- the swine barns at county fairs. Scientists … Read more

UI-ISU researchers team up to advance state bioscience priorities

Researchers from the University of Iowa (UI) and Iowa State University (ISU) are building joint teams that will work to use gut bacteria to treat chronic diseases, improve weather forecasts for … Read more

Ebola vaccine helps combat deadly outbreak in Congo as virus spreads

The Ebola virus is once again wreaking havoc in the war-torn North Kivu and Ituri provinces of the Democratic Republic of the Congo, claiming an estimated 1,625 lives so far in its second-deadliest … Read more

FDA qualifies biomarker in controlled malaria infection trials

A molecular test, proven more effective than thick blood smears at detecting malaria parasites earlier in an infection, has now received Food and Drug Administration qualification for certain types of … Read more

Back to the top